Our mission is to promote, protect, and improve the health of identified Hoosier babies with genetic conditions and birth defects.
What is the Genomics and Newborn Screening Program?
The Genomics and Newborn Screening Program (GNBS) is an ISDH program that houses the Indiana Birth Defects and Problems Registry (IBDPR) and is responsible for ensuring timely and quality newborn screening occurs for each and every Hoosier baby. Visit our IBDPR and Newborn Screening pages for more information.
Important Updates for Genomics and Newborn Screening Stakeholders
07/2020: GNBS Education Initiative on hold - The GNBS Education Specialist position is now vacant. We are currently developing targeted online education modules that will be offered to our birthing partners, PCPs, and MSR reporters. Once finished, these modules will be available to staff to access 24/7 at their leisure. We will let our stakeholders know when these modules are ready to be accessed via our GNBS email listserv. Click here to receive GNBS updates via email!
07/2020: Indiana now screens for Krabbe, Pompe and MPS-1/Hurler Syndrome - Senate Bill 41 was signed into law on March 25th, 2019. This will add three more conditions to the IN newborn screening panel. The panel will now include Krabbe disease, Pompe disease and Hurler Syndrome (MPS-1). This will increase the current number of conditions screened via heel stick screening to over 50 conditions.. Screening began on July 1, 2020. For more information about this program update, click here.
With the addition of these screens, we will also included a newborn screening fee increase that began on July 1, 2020. The $100 newborn screening fee increased to $115 to allow for the lysosomal disorder screening, follow-up and wrap-around services, such as confirmatory testing, genetic counseling and other healthcare needs for those detected conditions.
If you have any questions or additional need of support in implementing this change, please contact us at our shared inbox ISDHNBS@isdh.IN.gov.
04/2020: COVID-19 NBS Updates from the American Academy of Pediatrics - ISDH encourages healthcare providers and other GNBS stakeholders to review the Guidance on Newborn Screening During COVID-19 and other related critical updates on health care for children during the COVID-19 pandemic. For more information on GNBS and COVID-19, view our Spring Newsletter.
Subscribe to our Newsletter!
Interested in receiving information and updates about Genomics and Newborn Screening?
Page last revised on 07/14/2020 by JHaller